Bcl-2 Exerts a pRb-Mediated Cell Cycle Inhibitory Function in HEC1B Endometrial Carcinoma Cells

This publication has 17 references indexed in Scilit:

• Differential Expression of Antiapoptotic Genes in Human Endometrial Carcinoma: bcl-XL Succeeds bcl-2 Function in Neoplastic Cells
  Gynecologic Oncology, 2000
• Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model
  Oncogene, 1999
• Effects of Differential Overexpression of Bcl-2 on Apoptosis, Proliferation, and Telomerase Activity in Jurkat T Cells
  Experimental Cell Research, 1999
• Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21WAF1/CIP1 and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity
  Oncogene, 1999
• Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth
  Oncogene, 1998
• Lack of bcl-2 Persistence: An Independent Prognostic Indicator of Poor Prognosis in Endometrial Carcinoma
  Gynecologic Oncology, 1998
• BCL-2 FAMILY: Regulators of Cell Death
  Annual Review of Immunology, 1998
• Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death.
  The Journal of Experimental Medicine, 1996
• Bcl-2 and the regulation of programmed cell death
  The Journal of cell biology, 1994
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970